SCHEMBL19110449

SCHEMBL19110449

CC1(C)c2ccccc2-c2cc(-c3c4ccccc4c(-c4ccc5c(c4)sc4ccc6c(ccc7c8ccccc8sc76)c45)c4ccccc34)ccc21

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.36
MAPT P10636 2/20 0.34
ALDH1A1 P00352 1/20 0.34
HPGD P15428 1/20 0.34
RAB9A P51151 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
PTPN1 P18031 1/20 0.31
MEN1 O00255 1/20 0.31
POLB P06746 1/20 0.31
DUSP3 P51452 1/20 0.31
BLM P54132 1/20 0.31
PTPN5 P54829 1/20 0.31
KMT2A Q03164 1/20 0.31
PTPN11 Q06124 1/20 0.31
MCL1 Q07820 1/20 0.31
CTDSP1 Q9GZU7 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
LIMK1 P53667 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19110276 0.95 MAPT (0.35) MAPTALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL17944889 0.89 MAPT (0.33) ALOX5MAPTALDH1A1HPGDRAB9A
SCHEMBL19110293 0.89 ALOX5 (0.40) ALOX5MAPTALDH1A1HPGDRAB9A
SCHEMBL19077514 0.89 CHEK1 (0.31) ALOX5MAPTPTPN1MEN1POLB
SCHEMBL19110294 0.88 ALOX5 (0.34) ALOX5MAPTPTPN1MEN1POLB
SCHEMBL19110283 0.88 ALOX5 (0.36) ALOX5MAPTPTPN1
SCHEMBL19110281 0.87 MAPT (0.33) MAPTALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL19077520 0.87 ALOX5 (0.34) ALOX5
SCHEMBL17944257 0.87 ALDH1A1 (0.32) ALOX5MAPTALDH1A1HPGDRAB9A
SCHEMBL17945744 0.87 ALDH1A1 (0.32) ALOX5MAPTALDH1A1HPGDRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11276827-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2022-03-15 US disclosed
US-20170200905-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-13 US disclosed
US-20170200905-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170200905-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNA1 ALOX5 1871/4885MAPT 1538/4885ALDH1A1 237/4885
US-11276827-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNA1 ALOX5 1871/4885MAPT 1538/4885ALDH1A1 237/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.